Aircraft, drug royalty ABS fill crowded esoteric pipeline

A $150m drug royalty offering from DRI Capital, a Toronto-based healthcare royalty fund manager, and a $612m aircraft ABS from Apollo Aviation Management have hit the market as bids heat up for esoteric ABS paper in the second quarter.